BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8215878)

  • 1. Use of erythropoietin and parenteral iron dextran in a severely anemic Jehovah's Witness with colon cancer.
    Madura JA
    Arch Surg; 1993 Oct; 128(10):1168-70. PubMed ID: 8215878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant human erythropoietin in a Jehovah's Witness.
    Koenig HM; Levine EA; Resnick DJ; Meyer WJ
    J Clin Anesth; 1993; 5(3):244-7. PubMed ID: 8318245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of recombinant human erythropoietin in a Jehovah's Witness requiring major reconstructive surgery.
    Connor JP; Olsson CA
    J Urol; 1992 Jan; 147(1):131-2. PubMed ID: 1729504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of post-traumatic acute anemia by recombinant human erythropoietin in Jehovah's Witnesses].
    Streef C; Charpentier C; Audibert G; Laxenaire MC
    Ann Fr Anesth Reanim; 1996; 15(8):1199-202. PubMed ID: 9636794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies.
    Gannon CJ; Napolitano LM
    Crit Care Med; 2002 Aug; 30(8):1893-5. PubMed ID: 12163811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury.
    Boshkov LK; Tredget EE; Janowska-Wieczorek A
    Am J Hematol; 1991 May; 37(1):53-4. PubMed ID: 2024641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses].
    Soukup J; Menzel M; Roth S; Radke J
    Anaesthesist; 1996 Aug; 45(8):745-9. PubMed ID: 8967587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in kidney transplantation without blood transfusion: kidney transplantation transfusion-free in Jehovah's Witnesses. First communication in Mexico].
    Hernández-Navarrete LS; Hernández-Jiménez JD; Jiménez-López LA; Budar-Fernández LF; Méndez-López MT; Martínez-Mier G
    Cir Cir; 2013; 81(5):450-3. PubMed ID: 25125065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid restoration of red blood cell mass in severely anemic surgical patients who refuse transfusion.
    Dudrick SJ; O'Donnell JJ; Raleigh DP; Matheny RG; Unkel SP
    Arch Surg; 1985 Jun; 120(6):721-7. PubMed ID: 3924007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 44-year-old Jehovah's Witness with life-threatening anemia from uterine bleeding.
    Hashem B; Dillard TA
    Chest; 2004 Mar; 125(3):1151-4. PubMed ID: 15006982
    [No Abstract]   [Full Text] [Related]  

  • 11. A protocol avoiding allogeneic transfusion in joint arthroplasties.
    Suh YS; Nho JH; Choi HS; Ha YC; Park JS; Koo KH
    Arch Orthop Trauma Surg; 2016 Sep; 136(9):1213-1226. PubMed ID: 27450193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant human erythropoietin to avoid blood transfusion in a Jehovah's Witness requiring hemispherectomy. Case report.
    Schiff SJ; Weinstein SL
    J Neurosurg; 1993 Oct; 79(4):600-2. PubMed ID: 8410232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization.
    Tanaka A; Ota T; Uriel N; Asfaw Z; Onsager D; Lonchyna VA; Jeevanandam V
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):976-83.e1-3. PubMed ID: 26211405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of recombinant human erythropoietin in a Jehovah's Witness with a thermal injury.
    Deitch EA; Guillory D; Cruz N
    J Burn Care Rehabil; 1994; 15(1):42-5. PubMed ID: 8150842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe anemia in the Jehovah's Witness: case report and discussion.
    Collins SL; Timberlake GA
    Am J Crit Care; 1993 May; 2(3):256-9. PubMed ID: 8364678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's witness.
    McLoughlin PL; Cope TM; Harrison JC
    Anaesthesia; 1999 Sep; 54(9):891-5. PubMed ID: 10460565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of desmopressin and erythropoietin in an anaemic Jehovah's Witness patient with severely impaired coagulation capacity undergoing stentless aortic valve replacement.
    Beholz S; Liu J; Thoelke R; Spiess C; Konertz W
    Perfusion; 2001 Nov; 16(6):485-9. PubMed ID: 11761088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective therapy of human immunodeficiency virus-associated anemia with recombinant human erythropoietin despite high endogenous erythropoietin.
    DaCosta NA; Hultin MB
    Am J Hematol; 1991 Jan; 36(1):71-2. PubMed ID: 1984688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.